Photo: academy.eahad.org
May 1, 2026, 13:23
Key Advances Across the Full Spectrum of VWD at EAHAD 2025
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
”A century of progress in von Willebrand Disease continues to shape how we diagnose, understand, and treat patients today.
At EAHAD 2025, this session featured Carlo Castaman, Omid Seidizadeh, and Jeroen Eikenboom to explore key advances across the full spectrum of VWD.
Missed the live session? Relive the insights anytime on EAHAD Academy.”
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared this post on LinkedIn, adding:
”It was my pleasure to be invited to contribute to this EAHAD session on von Willebrand Disease.”
Stay updated with Hemostasis Today.
-
Sep 27, 2026, 13:31Mohamud Abdullahi Mohamed: Essential Resource for Clinical Hematology Diagnostics
-
Sep 27, 2026, 13:19Julie Makani: Advances and Challenges in Sickle Cell and Beta Thalassemia Treatment
-
Sep 27, 2026, 12:56Ana Lidia Flores-Mireles: Fibrin Suppresses Macrophage Defenses in Catheter-Associated UTIs
-
Sep 27, 2026, 12:30Francesco Onida: Maria Domenica Cappellini Receives 2026 Lettura Ferrata Award
-
Sep 27, 2026, 11:51Ashraf Dada: Smart Algorithm Enables Successful Single-Session Stem Cell Collection
-
Sep 27, 2026, 09:03Tareq Abadl: Hemoglobin Electrophoresis Patterns Across Thalassemia Syndromes
-
Sep 27, 2026, 08:33Vincent Serra: Beyond Oncology The Expanding Landscape of Immunotherapy
-
Sep 27, 2026, 08:18Tanmoy Debnath: Multiplexed Genetic Screening From a Single Newborn Blood Spot
-
Sep 27, 2026, 07:57Christopher D: Personalized CRISPR Therapy and the Future of Rare Disease Care